Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing disease progression using a composite endpoint.

Weng Kee Wong1, Daniel E Furst, Philip J Clements

  • 1Department of Biostatistics, University of California at Los Angeles, CA, USA. wkwong@ucla.edu

Statistical Methods in Medical Research
|March 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Seminars in arthritis and rheumatism·2026
Same author

Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium.

Expert review of clinical immunology·2026
Same author

Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases.

Annals of the rheumatic diseases·2026
Same author

Integrated single-cell transcriptomic analysis identifies <i>PF4</i> <sup><i>+</i></sup> <i>/PPBP</i> <sup><i>+</i></sup> megakaryocyte-like granulocytes associated with immune dysregulation in autoimmune diseases.

Biochemistry and biophysics reports·2026
Same author

Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy.

RMD open·2026
Same author

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Seminars in arthritis and rheumatism·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
Same journal

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
See all related articles

This study introduces a new composite index for evaluating scleroderma patients by analyzing

Area of Science:

  • Rheumatology and Clinical Trials
  • Biostatistics and Health Outcomes Research

Background:

  • Scleroderma frequently causes severe multi-organ system medical events.
  • Existing methods may not fully capture disease activity across all affected systems.

Purpose of the Study:

  • To develop and illustrate a composite 'time to event' analysis for evaluating chronic disease activity.
  • To propose methods for monitoring patient improvement using composite endpoints and desirability functions.

Main Methods:

  • Utilized composite 'time to event' analysis with a composite endpoint and Kaplan-Meier analysis.
  • Applied data from a scleroderma clinical trial for illustration.
  • Conducted sensitivity analyses by modifying organ involvement criteria.

Related Experiment Videos

Main Results:

  • Demonstrated the application of composite 'time to event' analysis in scleroderma.
  • Proposed desirability functions for continuous outcome monitoring.
  • Highlighted potential advantages over current patient improvement measurement methods.

Conclusions:

  • Composite 'time to event' analysis offers a robust framework for evaluating chronic diseases like scleroderma.
  • The proposed methods provide a more comprehensive approach to assessing disease activity and patient improvement.